How to buy Purple Biotech stock | $4.51

Purple Biotech Ltd is a biotechnology business based in the US. Purple Biotech shares (PPBT) are listed on the NASDAQ and all prices are listed in US Dollars. Purple Biotech employs 13 staff and has a market cap (total outstanding shares value) of 0.00.

Purple Biotech stock price (NASDAQ: PPBT)

Use our graph to track the performance of PPBT stocks over time.

Purple Biotech shares at a glance

• Key figures

Information last updated 2021-10-16.

Latest market close	$4.51
52-week range	$3.60 - $7.25
50-day moving average	$4.73
200-day moving average	$4.69
Wall St. target price	$25.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.60

Buy Purple Biotech shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Purple Biotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Purple Biotech price performance over time

Historical closes compared with the close of $4.51 from 2021-10-22

1 week (2021-10-15)	-1.31%
1 month (2021-09-24)	-5.85%
3 months (2021-07-23)	-8.89%
6 months (2021-04-23)	-0.88%

1 year (2020-10-23)	-4.65%
2 years (2019-10-23)	5,994.59%
3 years (2018-10-23)	2,989.04%
5 years (2016-10-21)	1,041.77%

Purple Biotech financials

Gross profit TTM	$1 million
Return on assets TTM	-14.29%
Return on equity TTM	-16.33%
Profit margin	0%
Book value	$4.10
Market capitalisation	$80.5 million

TTM: trailing 12 months

Shorting Purple Biotech shares

There are currently 1.1 million Purple Biotech shares held short by investors – that's known as Purple Biotech's "short interest". This figure is 8.4% down from 1.2 million last month.

There are a few different ways that this level of interest in shorting Purple Biotech shares can be evaluated.

Purple Biotech's "short interest ratio" (SIR)

Purple Biotech's "short interest ratio" (SIR) is the quantity of Purple Biotech shares currently shorted divided by the average quantity of Purple Biotech shares traded daily (recently around 113274.8496994). Purple Biotech's SIR currently stands at 9.98. In other words for every 100,000 Purple Biotech shares traded daily on the market, roughly 9980 shares are currently held short.

However Purple Biotech's short interest can also be evaluated against the total number of Purple Biotech shares, or, against the total number of tradable Purple Biotech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Purple Biotech's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Purple Biotech shares in existence, roughly 60 shares are currently held short) or 0.0695% of the tradable shares (for every 100,000 tradable Purple Biotech shares, roughly 70 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Purple Biotech.

Find out more about how you can short Purple Biotech stock.

Purple Biotech share dividends

We're not expecting Purple Biotech to pay a dividend over the next 12 months.

Have Purple Biotech's shares ever split?

Purple Biotech's shares were split on a 1:10 basis on 20 August 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Purple Biotech shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Purple Biotech shares which in turn could have impacted Purple Biotech's share price.

Purple Biotech share price volatility

Over the last 12 months, Purple Biotech's shares have ranged in value from as little as $3.6 up to $7.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Purple Biotech's is 1.9207. This would suggest that Purple Biotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Purple Biotech overview

Purple Biotech Ltd. , a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension. Its oncology pipeline includes NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020.

Frequently asked questions

What percentage of Purple Biotech is owned by insiders or institutions?
Currently 1.869% of Purple Biotech shares are held by insiders and 22.859% by institutions. How many people work for Purple Biotech?
Latest data suggests 13 work at Purple Biotech. When does the fiscal year end for Purple Biotech?
Purple Biotech's fiscal year ends in December. Where is Purple Biotech based?
Purple Biotech's address is: 4 Oppenheimer Street, Rehovot, Israel, 7670104 What is Purple Biotech's ISIN number?
Purple Biotech's international securities identification number is: US74638P1093